Benitec Lays Off Half of US Staff, Trims Drug-Development Programs in Cost-Cutting Effort | GenomeWeb

NEW YORK, April 18 (GenomeWeb News) - Benitec said today that it has cut its US workforce in half in an effort to reduce the operational expenses of its US subsidiary.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.